<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="139501">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01284933</url>
  </required_header>
  <id_info>
    <org_study_id>ISD-CAPIAS-01</org_study_id>
    <nct_id>NCT01284933</nct_id>
  </id_info>
  <brief_title>Carotid Plaque Imaging in Acute Stroke</brief_title>
  <acronym>CAPIAS</acronym>
  <official_title>Carotid Plaque Imaging in Acute Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ludwig-Maximilians - University of Munich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the frequency, characteristics, and consequences
      of vulnerable carotid artery plaques ipsilateral to an acute ischemic stroke or TIA in the
      territory of the internal carotid artery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Even with extensive diagnostic workup the underlying etiology remains unidentified in about
      25% of patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA).
      Non-invasive high-resolution magnetic resonance imaging (HR-MRI) of the carotid artery
      allows detecting vulnerable plaques (VP) and quantifying single plaque components. The
      hypotheses behind this study are that i) a substantial proportion of cases of AIS and TIA
      within the anterior circulation and no identified cause (cryptogenic AIS or TIA) are caused
      by VP in the carotid artery; ii) that these patients are at a high risk of developing a
      recurrent stroke, TIA, or clinically silent lesions detectable by brain MRI; and iii) that
      VP in the carotid artery are associated with specific infarct patterns as detected by
      diffusion-weighted MR imaging. Finally, the investigators will search for biomarkers
      associated with vulnerable carotid artery plaques. Motivating this study are the following
      considerations: i) data on the frequency and characteristics of VP in patients with
      cryptogenic AIS or TIA will provide valuable insights into stroke mechanisms; ii) depending
      on the results this study may have implications for diagnostic decision making and provide
      the basis for the planning of targeted interventional studies.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2011</start_date>
  <primary_completion_date>December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency and characteristics of vulnerable plaques (VP) in the carotid artery ipsilateral to an acute ischemic stroke (AIS) or TIA in the territory of the carotid artery in patients with a cryptogenic stroke</measure>
    <time_frame>Baseline</time_frame>
    <description>For the primary outcome definition of a VP will be based on non-invasive high-resolution magnetic resonance imaging (MRI). Vulnerable plaques are defined as American Heart Association (AHA) class VI plaques (Cai et al. Circulation 2002; Saam et al.)
Comparisons will include:
a comparison of the frequency and characteristics of VP ipsilateral vs. contralateral to the AIS or TIA
a comparison of the frequency and characteristics of ipsilateral VP in patients with cryptogenic stroke as compared to patients with cardioembolic stroke or small vessel stroke</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pattern of acute ischemic lesions on brain MRI associated with VP in the carotid artery</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence rates of AIS or TIA in patients with VP in the carotid artery</measure>
    <time_frame>12 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of new ischemic lesions on FLAIR MRI at 12 month follow-up in patients with VP in the carotid artery</measure>
    <time_frame>12 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association between VP in the carotid artery and atherosclerotic plaques in the aortic arch as determined by transoesophageal ultrasound</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarkers associated with vulnerable carotid artery plaques</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Stroke</condition>
  <condition>Ischemic Attack, Transient</condition>
  <arm_group>
    <arm_group_label>Acute Ischemic Stroke, Transient Ischemic Attack</arm_group_label>
    <description>Patients admitted to a specialized stroke service because of an acute stroke or TIA</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum, plasma, RNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to a specialized stroke service because of an acute stroke or TIA
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 49 years old

          -  Acute ischemic stroke or transient ischemic attack (TIA)

          -  Neurological symptoms compatible with a stroke or TIA in the anterior circulation
             (territory of the internal carotid artery)

          -  Onset of symptoms within the last 7 days

          -  1 or more acute ischemic lesion(s) visible on MR diffusion-weighted imaging (DWI) in
             the territory of a single internal carotid artery

          -  Presence of carotid artery plaques in the ipsilateral or contralateral carotid artery
             as defined by ultrasound (criteria: plaque thickness at least 2mm; located within 1cm
             proximal or distal to the carotid bifurcation)

          -  Written informed consent

        Exclusion Criteria:

          -  Primary referral to an outside hospital (to avoid recruitment bias)

          -  DWI positive lesions outside the territory of a single internal carotid artery

          -  Carotid artery stenosis &gt; 69% (North American Symptomatic Carotid Endarterectomy
             Trial (NASCET) criteria) ipsilateral to the stroke or TIA as defined by ultrasound
             (systolic peak flow velocity ≥ 300 cm/s)

          -  Standard contra-indications for MRI

          -  Documented allergy to MRI contrast media

          -  History of radiation to the neck area

          -  Renal clearance &lt; 30 ml/minute

          -  Creatinine levels &gt; 2 times the upper limit of the standard range of the respective
             laboratory within the last 30 days prior to MRI

          -  Surgical procedure within 24 hours preceding the MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Dichgans, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Interdisciplinary Stroke Center Munich, Klinikum der Universität München, Campus Großhadern</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tobias Saam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Interdisciplinary Stroke Center Munich, Klinikum der Universität München, Campus Großhadern</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin Dichgans, Prof.</last_name>
    <phone>+49-89-7095</phone>
    <phone_ext>8310</phone_ext>
    <email>martin.dichgans@med.uni-muenchen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tobias Saam, MD</last_name>
    <phone>+49-89-7095</phone>
    <phone_ext>3658</phone_ext>
    <email>tobias.saam@med.uni-muenchen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Freiburg, Germany</name>
      <address>
        <city>Freiburg</city>
        <state>Baden Württemberg</state>
        <zip>D-79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Harloff, MD</last_name>
      <phone>++49-0761 270</phone>
      <phone_ext>50010</phone_ext>
      <email>andreas.harloff@uniklinik-freiburg.de</email>
    </contact>
    <investigator>
      <last_name>Andreas Harloff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Interdisciplinary Stroke Center Munich, Klinikum der Universität München, Campus Großhadern</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Dichgans, Prof.</last_name>
      <phone>+49-89-7095</phone>
      <phone_ext>8330</phone_ext>
      <email>martin.dichgans@med.uni-muenchen.de</email>
    </contact>
    <contact_backup>
      <last_name>Tobias Saam, MD</last_name>
      <phone>+49-89-7095</phone>
      <phone_ext>118</phone_ext>
      <email>tobias.saam@med.uni-muenchen.de</email>
    </contact_backup>
    <investigator>
      <last_name>Martin Dichgans, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tobias Saam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum re. der Isar, Technical University Munich</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holger Poppert, MD</last_name>
      <phone>+49-89-4140</phone>
      <phone_ext>4606</phone_ext>
      <email>poppert@gmx.de</email>
    </contact>
    <investigator>
      <last_name>Holger Poppert, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Tuebingen</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulf Ziemann, Prof.</last_name>
      <phone>0049 70712982049</phone>
      <email>ulf.ziemann@med.uni-tuebingen.de</email>
    </contact>
    <contact_backup>
      <last_name>Ulrike Ernemann, Prof.</last_name>
      <phone>0049 7071298 60 24</phone>
      <email>ulrike.ernemann@med.uni-muenchen.de</email>
    </contact_backup>
    <investigator>
      <last_name>Ulf Ziemann, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ulrike Ernemann, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.klinikum.uni-muenchen.de/Interdisziplinaeres-Schlaganfallzentrum/en/index.html</url>
    <description>Click here for more information</description>
  </link>
  <link>
    <url>http://www.klinikum.uni-muenchen.de/Institut-fuer-Schlaganfall-und-Demenzforschung/en/index.html</url>
    <description>Click here for more information</description>
  </link>
  <reference>
    <citation>Bayer-Karpinska A, Schwarz F, Wollenweber FA, Poppert H, Boeckh-Behrens T, Becker A, Clevert DA, Nikolaou K, Opherk C, Dichgans M, Saam T. The carotid plaque imaging in acute stroke (CAPIAS) study: protocol and initial baseline data. BMC Neurol. 2013 Dec 13;13:201. doi: 10.1186/1471-2377-13-201.</citation>
    <PMID>24330333</PMID>
  </reference>
  <reference>
    <citation>Schwarz F, Bayer-Karpinska A, Poppert H, Buchholz M, Cyran C, Grimm J, Helck A, Nikolaou K, Opherk C, Dichgans M, Saam T. Serial carotid MRI identifies rupture of a vulnerable plaque resulting in amaurosis fugax. Neurology. 2013 Mar 19;80(12):1171-2. doi: 10.1212/WNL.0b013e31828869ad.</citation>
    <PMID>23509049</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <lastchanged_date>March 24, 2016</lastchanged_date>
  <firstreceived_date>January 24, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ludwig-Maximilians - University of Munich</investigator_affiliation>
    <investigator_full_name>Martin Dichgans</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Ischemic Attack, Transient</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>Carotid Arteries</keyword>
  <keyword>Carotid Artery Plaque</keyword>
  <keyword>Atherosclerosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Attack, Transient</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
